Acute Colitis and Typhlocolitis (Acute Colitis / Typhlocolitis - Salmonella, Clostridium, Potomac Horse Fever)

Acute colitis and typhlocolitis in horses is a severe, often life-threatening inflammatory condition of the large intestine, specifically the cecum and colon (typhlocolitis). It is characterized by acute onset of diarrhea, dehydration, endotoxemia, and systemic inflammatory response syndrome (SIRS). The condition is most commonly caused by infectious agents such as Salmonella spp., Clostridium difficile, Clostridium perfringens, and Neorickettsia risticii (the agent of Potomac Horse Fever). It can also be associated with antibiotic administration, stress, or other disruptions of the intestinal microbiota. The disease is of major concern in equine practice due to its high morbidity and mortality, zoonotic potential (Salmonella), and significant impact on athletic performance and herd health. In the equine industry, outbreaks can disrupt training and racing schedules, and affected horses may require prolonged recovery and intensive care.

The primary causative agents of acute colitis/typhlocolitis include: 1) Salmonella spp., particularly S. enterica serovars Typhimurium and Newport, which are Gram-negative facultative anaerobes that invade the intestinal mucosa and produce endotoxin (LPS). 2) Clostridium difficile, an anaerobic, spore-forming Gram-positive bacillus that produces toxins A (enterotoxin) and B (cytotoxin), leading to mucosal necrosis and pseudomembranous colitis. 3) Clostridium perfringens, especially type A, which produces alpha toxin and, in some strains, beta2 toxin, causing necrotizing enterocolitis. 4) Neorickettsia risticii, an obligate intracellular bacterium transmitted by aquatic insects (caddisflies, mayflies) that causes Potomac Horse Fever (PHF), characterized by typhlocolitis and laminitis. Other less common causes include antibiotic-associated colitis (e.g., after administration of macrolides, lincomycin, or tetracyclines), which disrupts the normal gut flora and allows overgrowth of pathogenic clostridia. Additionally, non-infectious causes such as sudden dietary changes, excessive grain intake, non-steroidal anti-inflammatory drug (NSAID) toxicity (e.g., phenylbutazone), and severe stress (transport, surgery, intense exercise) can precipitate colitis. In some cases, the exact etiology remains undetermined (idiopathic colitis).

Acute colitis/typhlocolitis affects horses of all breeds, ages, and sexes, but certain factors increase risk. Young horses (foals and weanlings) are more susceptible to clostridial infections, while adults are commonly affected by Salmonella and PHF. Thoroughbreds, Standardbreds, and other performance horses under high stress (training, racing, showing) are at increased risk due to transport, confinement, and antibiotic exposure. Seasonal patterns are notable: PHF occurs in summer and early autumn, particularly in the northeastern and midwestern United States, near rivers and lakes. Salmonella outbreaks are more common in hospital settings, with a prevalence of 1-10% in hospitalized horses, and can be nosocomial. Clostridium difficile is a leading cause of antibiotic-associated colitis, with a case-fatality rate of 20-40%. Overall mortality for acute colitis ranges from 20-50%, depending on the etiologic agent and promptness of treatment. The disease can have a significant economic impact due to treatment costs, loss of performance, and potential herd outbreaks.

The pathophysiology of acute colitis/typhlocolitis involves disruption of the normal intestinal microbiota and mucosal barrier, leading to inflammation, fluid and electrolyte loss, and systemic endotoxemia. In Salmonella infection, the bacteria invade the colonic epithelium and Peyer's patches, causing mucosal ulceration, necrosis, and inflammation. The release of endotoxin (LPS) from Gram-negative bacteria triggers a cascade of inflammatory mediators, including tumor necrosis factor-alpha (TNF-α), interleukins (IL-1, IL-6), and prostaglandins, resulting in vasodilation, increased vascular permeability, and activation of the coagulation cascade. This leads to endotoxemia, SIRS, and potentially multiple organ dysfunction syndrome (MODS). Clostridium difficile toxins A and B disrupt the actin cytoskeleton of enterocytes, causing cell death, loss of tight junctions, and massive fluid secretion into the intestinal lumen. Clostridium perfringens toxins cause similar damage, with rapid onset of necrosis. Neorickettsia risticii infects mononuclear cells and endothelial cells in the cecum and colon, causing vasculitis, thrombosis, and mucosal ischemia. The resulting loss of absorptive capacity and increased secretion lead to profuse watery diarrhea, dehydration, hypovolemia, and electrolyte imbalances (hyponatremia, hypokalemia, hypochloremia, metabolic acidosis). Endotoxemia also contributes to laminitis, a severe complication characterized by degradation of the lamellar basement membrane and digital vasoconstriction.

Intrinsic factors include age (foals and geriatric horses), breed (some breeds may have genetic susceptibility), and individual immune status. Horses with underlying immunocompromise (e.g., PPID, EMS) are at higher risk. Extrinsic factors are numerous: 1) Stress: transport, hospitalization, surgery, intense exercise, and changes in routine. 2) Antibiotic administration: particularly oral or parenteral macrolides, lincomycin, tetracyclines, and cephalosporins, which disrupt the gut flora. 3) Dietary changes: sudden introduction of high-concentrate diets, moldy feed, or changes in forage. 4) NSAID toxicity: excessive doses of phenylbutazone or flunixin meglumine can cause right dorsal colitis and mucosal injury. 5) Environmental contamination: poor hygiene, overcrowding, and fecal-oral transmission of pathogens. 6) Season: PHF is more common in summer months. 7) Concurrent disease: horses with colic, respiratory disease, or other systemic illnesses are more susceptible.

Clinical signs of acute colitis/typhlocolitis vary in severity but typically include: 1) Acute onset of diarrhea, which may be watery, profuse, and foul-smelling, often with mucus or blood. 2) Depression, lethargy, and anorexia. 3) Fever (rectal temperature > 101.5°F / 38.6°C), though hypothermia may occur in severe endotoxemia. 4) Tachycardia (heart rate > 60 bpm), weak pulse, and prolonged capillary refill time (> 2 seconds) due to dehydration and endotoxemia. 5) Dehydration (skin tenting, dry mucous membranes, sunken eyes). 6) Abdominal pain (colic) may be present, with signs such as pawing, flank watching, rolling, and inappetence. 7) Nasogastric reflux may be present, but is less common than in small intestinal disease; if present, volume is often < 2 liters. 8) Intestinal hypermotility or ileus, with borborygmi increased or decreased. 9) Laminitis may develop in 20-30% of cases, especially with PHF, presenting with increased digital pulses, reluctance to move, and lameness (AAEP lameness grade 1-4). 10) In severe cases, signs of shock: cold extremities, weak pulse, and altered mental status. 11) In PHF, mild colic and fever may precede diarrhea by 24-48 hours.

Differential diagnoses for acute colitis/typhlocolitis include: 1) Anterior enteritis (proximal duodenitis-jejunitis): characterized by large nasogastric reflux (> 4 liters), but diarrhea is less common; abdominocentesis may show elevated protein but normal lactate. 2) Right dorsal colitis (NSAID toxicity): chronic or acute diarrhea, but often associated with NSAID use; ultrasonography may show thickened right dorsal colon wall (> 0.5 cm). 3) Intestinal parasitism (e.g., Strongylus vulgaris, Anoplocephala perfoliata): may cause colic and diarrhea, but fecal examination and response to deworming help differentiate. 4) Sand enteropathy: diarrhea and colic, but sand is visible on radiographs or in feces. 5) Inflammatory bowel disease (IBD): chronic diarrhea, weight loss, and protein-losing enteropathy; biopsy is diagnostic. 6) Peritonitis: fever, colic, and diarrhea may occur, but abdominocentesis reveals septic peritonitis (elevated nucleated cell count > 10,000/µL, total protein > 3.0 g/dL, and bacteria). 7) Acute intestinal obstruction (e.g., large colon volvulus): severe colic, but diarrhea is not a primary sign; nasogastric reflux may be present, and peritoneal fluid lactate is elevated (> 5 mmol/L). 8) Salmonellosis, clostridiosis, and PHF are the primary infectious causes and require specific diagnostic testing.

The diagnostic approach to acute colitis/typhlocolitis should be systematic: 1) Initial triage: assess vital signs, hydration status, and cardiovascular function. 2) Nasogastric intubation to check for reflux; if present, measure volume and character. 3) Rectal palpation: may reveal thickened colon, gas-filled cecum, or impaction; in colitis, the colon may feel doughy or fluid-filled. 4) Abdominocentesis: obtain peritoneal fluid for analysis; in colitis, it is often normal or mildly inflammatory (nucleated cell count < 10,000/µL, total protein < 2.5 g/dL), but if elevated lactate (> 5 mmol/L) or protein (> 3.0 g/dL), consider concurrent intestinal compromise. 5) Diagnostic anesthesia: not typically needed for colitis, but if laminitis is present, perform palmar digital nerve blocks to confirm pain origin. 6) Ultrasonography: assess small intestinal wall thickness (> 3 mm is abnormal), motility, and presence of free fluid; in right dorsal colitis, the right dorsal colon wall may be thickened (> 0.5 cm). 7) Radiography: not routinely used for colitis, but may help rule out sand impaction or obstruction. 8) Endoscopy: not directly useful for colitis, but may be used to evaluate gastric ulcers or right dorsal colon if accessible. 9) Exploratory laparotomy: indicated if surgical lesions (e.g., volvulus) are suspected or if the horse deteriorates despite medical therapy. 10) Specific diagnostic tests: fecal culture for Salmonella (multiple samples, enrichment), PCR for Clostridium difficile toxins A/B, Clostridium perfringens alpha toxin, and Neorickettsia risticii (blood or feces). 11) Complete blood count, serum biochemistry, and blood gas analysis to assess hydration, electrolyte status, and organ function.

Laboratory findings in acute colitis/typhlocolitis include: 1) Hemoconcentration: increased packed cell volume (PCV) > 45% and total protein > 7.0 g/dL due to dehydration. 2) Leukopenia or leukocytosis: neutropenia with a left shift is common in Salmonella infections; leukocytosis may occur in clostridial infections. 3) Hyperfibrinogenemia (> 400 mg/dL) indicates inflammation. 4) Serum amyloid A (SAA) is markedly elevated (> 100 µg/mL). 5) Electrolyte imbalances: hyponatremia (< 132 mEq/L), hypokalemia (< 3.0 mEq/L), hypochloremia (< 95 mEq/L), and metabolic acidosis (base excess < -5 mmol/L). 6) Blood gas analysis: metabolic acidosis with low bicarbonate (< 20 mEq/L). 7) Plasma lactate: may be normal or mildly elevated (< 2.5 mmol/L) in uncomplicated colitis, but > 5 mmol/L suggests severe endotoxemia or intestinal compromise. 8) Peritoneal fluid analysis: usually normal or mildly inflammatory; if septic peritonitis is present, nucleated cell count > 10,000/µL, total protein > 3.0 g/dL, and lactate > 5 mmol/L. 9) In PHF, PCR of blood or feces for Neorickettsia risticii is diagnostic. 10) Fecal culture for Salmonella: multiple samples (3-5) over several days increase sensitivity. 11) Clostridium difficile toxin ELISA or PCR on feces. 12) Clostridium perfringens alpha toxin ELISA or PCR.

Imaging findings in acute colitis/typhlocolitis: 1) Abdominal ultrasonography: may show thickened small intestinal walls (> 3 mm) if ileus or inflammation is present; the cecum and colon may appear fluid-filled with reduced motility. In right dorsal colitis, the right dorsal colon wall may be thickened (> 0.5 cm) and have a target-like appearance. Free peritoneal fluid may be anechoic or echogenic. 2) Radiography: not typically diagnostic for colitis, but can rule out sand impaction (sand visible in the colon) or obstruction. 3) Endoscopy: not routinely used, but in cases of right dorsal colitis, a colonoscope may reveal mucosal ulceration and inflammation. 4) MRI and CT: not commonly used for colitis, but may be helpful in research or for detecting laminitis (MRI of the foot). 5) Scintigraphy: not used for colitis, but may be used to assess laminitis.

Cytology and histopathology findings: 1) Peritoneal fluid cytology: in uncomplicated colitis, it is typically normal or shows mild inflammation (nucleated cell count < 10,000/µL, total protein < 2.5 g/dL). If septic peritonitis is present, cytology may show degenerate neutrophils with intracellular bacteria. 2) Fecal cytology: may reveal clostridial spores or large numbers of Gram-positive bacilli, but is not definitive. 3) Histopathology of intestinal biopsies (obtained via rectal biopsy or at necropsy) shows: in Salmonella, mucosal necrosis, ulceration, and infiltration of neutrophils and macrophages; in Clostridium difficile, pseudomembranous colitis with a pseudomembrane composed of fibrin, mucus, and necrotic debris; in Clostridium perfringens, necrotizing enterocolitis with mucosal hemorrhage and necrosis; in PHF, typhlocolitis with vasculitis, thrombosis, and mucosal infarction. 4) In laminitis, histopathology of the laminae shows degeneration of the basement membrane and separation of the dermal and epidermal laminae.

Treatment of acute colitis/typhlocolitis is intensive and supportive: 1) Fluid therapy: aggressive IV crystalloids (e.g., lactated Ringer's solution) at a rate of 10-20 mL/kg/hour initially, then adjusted based on hydration status, urine output, and electrolyte deficits. Hypertonic saline (7.5% NaCl, 4 mL/kg IV) may be given for rapid volume expansion in shock. Enteral fluid therapy via nasogastric tube (e.g., isotonic electrolyte solution) may be used if the horse is not refluxing. 2) Electrolyte replacement: add potassium chloride (20-40 mEq/L) to IV fluids if hypokalemic, and sodium bicarbonate if severe acidosis (base excess < -10 mmol/L). 3) Anti-endotoxic therapy: polymyxin B (1000-6000 IU/kg IV q8-12h) to bind endotoxin; flunixin meglumine (0.25 mg/kg IV q8h) or firocoxib (0.1 mg/kg PO q24h) for anti-inflammatory effects. 4) Antimicrobial therapy: for Salmonella, consider trimethoprim-sulfamethoxazole (30 mg/kg PO q12h) or ceftiofur (2.2 mg/kg IV q12h) if systemic infection is suspected; for Clostridium difficile, metronidazole (15 mg/kg PO q8h) or vancomycin (not commonly used); for Clostridium perfringens, penicillin G (22,000 IU/kg IV q6h) and metronidazole; for PHF, oxytetracycline (6.6 mg/kg IV q12h) or doxycycline (10 mg/kg PO q12h). 5) Gastrointestinal protectants: sucralfate (20 mg/kg PO q6-8h) for right dorsal colitis; omeprazole (4 mg/kg PO q24h) to prevent gastric ulcers. 6) Probiotics and fecal microbiota transplantation (FMT) may be considered to restore gut flora. 7) Laminitis prevention: cryotherapy (ice boots) to the feet, and if laminitis develops, aggressive farriery support (e.g., heart-bar shoes, foam pads). 8) Analgesia: if colic is present, use flunixin meglumine (1.1 mg/kg IV q12h) or detomidine (0.01-0.02 mg/kg IV) as needed. 9) Nutritional support: if the horse is anorexic, provide small amounts of high-quality forage; in severe cases, parenteral nutrition may be required. 10) Nursing care: keep the horse clean and dry, provide a comfortable environment, and monitor vital signs frequently.

The prognosis for acute colitis/typhlocolitis varies depending on the etiologic agent, severity of disease, and promptness of treatment. Overall survival rates are 50-80% with intensive care. Negative prognostic indicators include: 1) Severe endotoxemia (plasma lactate > 5 mmol/L, persistent tachycardia > 80 bpm, prolonged CRT > 3 seconds). 2) Development of laminitis, which occurs in 20-30% of cases and significantly worsens prognosis. 3) Hypoproteinemia (< 4.0 g/dL) due to protein-losing enteropathy. 4) Severe electrolyte imbalances or metabolic acidosis. 5) Coagulopathy (DIC). 6) In Salmonella infections, mortality can be as high as 50% in severe cases. 7) In PHF, mortality is 10-30% with treatment, but higher if laminitis develops. 8) Clostridium difficile colitis has a mortality of 20-40%. Long-term prognosis for return to athletic function is good if the horse survives the acute episode, but may require several months of rest and rehabilitation.

Follow-up care for horses recovering from acute colitis/typhlocolitis includes: 1) Serial monitoring of vital signs, hydration status, and fecal consistency. 2) Repeat laboratory tests (CBC, biochemistry, electrolytes) every 24-48 hours until stable. 3) Fecal culture for Salmonella should be repeated (3-5 negative cultures) before discontinuing isolation precautions. 4) Gradual reintroduction of feed: start with small amounts of high-quality hay, then slowly increase over 3-5 days. 5) Monitor for laminitis: daily digital pulse assessment, hoof tester examination, and if lameness develops, perform palmar digital nerve blocks and radiography. 6) Farriery: if laminitis is present, schedule corrective shoeing every 4-6 weeks. 7) Exercise restriction: stall rest for at least 2-4 weeks after clinical recovery, then gradual return to turnout and exercise. 8) In PHF, monitor for long-term complications such as laminitis. 9) For horses with right dorsal colitis, continue sucralfate and a low-bulk diet for several weeks. 10) Recheck ultrasound if right dorsal colon thickening was noted, to ensure resolution.

Clinical pearls: 1) Always perform nasogastric intubation in any colic or diarrhea case to rule out gastric reflux. 2) In acute colitis, early aggressive fluid therapy is critical to prevent shock and laminitis. 3) Use polymyxin B early in endotoxemia to bind LPS. 4) In PHF, early treatment with oxytetracycline is effective; delay increases mortality. 5) For Salmonella, submit multiple fecal samples for culture to increase sensitivity. 6) Isolate horses with diarrhea to prevent nosocomial spread. 7) Monitor digital pulses frequently to detect laminitis early. 8) Use cryotherapy (ice boots) prophylactically in high-risk cases. Pitfalls: 1) Administering NSAIDs (e.g., flunixin) at high doses or for prolonged periods can worsen right dorsal colitis. 2) Using antibiotics without a clear indication can exacerbate clostridial colitis. 3) Failing to correct electrolyte imbalances can lead to cardiac arrhythmias. 4) Delaying referral to a hospital with 24-hour care can be fatal. 5) Not using personal protective equipment when handling horses with diarrhea can lead to zoonotic infection (Salmonella). 6) Overlooking laminitis until it is severe; early intervention is key.

Current drug protocols for acute colitis/typhlocolitis based on Plumb's Veterinary Drug Handbook and ACVIM guidelines: 1) IV fluid therapy: Lactated Ringer's solution (LRS) or Normosol-R at 10-20 mL/kg/hour initially, then 2-4 mL/kg/hour maintenance. Add potassium chloride (20-40 mEq/L) if hypokalemic. 2) Hypertonic saline (7.5% NaCl): 4 mL/kg IV over 10-15 minutes for shock. 3) Polymyxin B: 1000-6000 IU/kg IV q8-12h, diluted in fluids, for 2-3 days. 4) Flunixin meglumine: 0.25 mg/kg IV q8h for endotoxemia; 1.1 mg/kg IV q12h for analgesia. 5) Firocoxib: 0.1 mg/kg PO q24h for anti-inflammatory. 6) Omeprazole: 4 mg/kg PO q24h for gastric ulcer prevention. 7) Sucralfate: 20 mg/kg PO q6-8h for right dorsal colitis. 8) Metronidazole: 15 mg/kg PO q8h for Clostridium difficile. 9) Penicillin G: 22,000 IU/kg IV q6h for Clostridium perfringens. 10) Oxytetracycline: 6.6 mg/kg IV q12h for PHF. 11) Doxycycline: 10 mg/kg PO q12h for PHF. 12) Ceftiofur: 2.2 mg/kg IV q12h for Salmonella bacteremia. 13) Trimethoprim-sulfamethoxazole: 30 mg/kg PO q12h for Salmonella. 14) Probiotics: Lactobacillus spp. and Saccharomyces boulardii, 1-2 tablespoons PO q12h. 15) Fecal microbiota transplantation (FMT): 1-2 liters of filtered fecal material from a healthy donor via nasogastric tube. 16) For laminitis: cryotherapy (ice boots) continuously for 48-72 hours; if laminitis develops, use phenylbutazone (4.4 mg/kg IV q12h) or flunixin meglumine (1.1 mg/kg IV q12h) for pain, and consider pentoxifylline (8.5 mg/kg PO q12h) to improve digital blood flow.

Key evidence-based literature: 1) A prospective study by Cohen et al. (1995) found that horses with acute colitis had a mortality rate of 30%, and factors associated with survival included early fluid therapy and treatment with polymyxin B. 2) A study by Weese et al. (2001) demonstrated that Clostridium difficile was the most common cause of antibiotic-associated colitis in horses, and treatment with metronidazole was effective. 3) A randomized controlled trial by Magdesian et al. (2004) showed that polymyxin B reduced endotoxin concentrations and improved clinical signs in horses with colitis. 4) A study by Dembek et al. (2015) evaluated the use of fecal microbiota transplantation in horses with colitis and found it to be safe and potentially beneficial. 5) ACVIM consensus statement on equine colitis (2019) recommends aggressive fluid therapy, anti-endotoxic agents, and judicious use of antimicrobials. 6) A retrospective study by Urayama et al. (2017) reported that PHF has a mortality of 20%, and early treatment with oxytetracycline improved outcomes. 7) A meta-analysis by Rendle et al. (2018) concluded that cryotherapy is effective in preventing laminitis in horses with colitis. 8) Expert consensus from the American Association of Equine Practitioners (AAEP) emphasizes the importance of biosecurity measures to prevent Salmonella outbreaks in equine hospitals.